Company page

Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

Vcanbio Cell & Gene Engineering Corp., Ltd. Class A, traded under the ticker 600645, is a public company based in China. The company focuses on advancements in cell and gene engineering technologies. As of now, Vcanbio has a market capitalization of approximately 1.37 billion USD.